As large multi-cancer datasets become more important for predicting who may benefit from cancer drugs, a new approach better accounts for potentially overlooked variation.

Urine test found to be extremely accurate at detecting aggressive prostate cancer with few false negatives.

Engineers and oncologists teamed to develop a microfluidic chip capable of capturing the body’s natural killer immune cells to harvest their cancer-killing exosomes.

A new understanding of intracellular pathways activated as T cells start to mount an immune response offers clues against graft-versus-host disease, a serious complication of bone marrow transplantation.

Implementing policies and strategies to eliminate racial disparities could improve outcomes for both diseases.

A combination approach, which included metabolic reprogramming and immunotherapy, led to complete tumor regression in 60% of study mice.